Join
Live feed
·
PRReleasevia Quantisnow
Quanterix Corporation logo

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection

ByQuantisnow·Wall Street's wire, on your screen.
QTRX· Quanterix Corporation
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QTRX (Quanterix Corporation) and more on Quantisnow.